Menu

Market Cap Distribution

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (47)

%
Company Market Cap Price
JNJ Johnson & Johnson 70%
Prosthetics & implants portfolio complements orthopedics and Cardiovascular/MedTech lines.
$458.89B
$190.72
-0.67%
ABT Abbott Laboratories 85%
The company develops and sells prosthetic implants and related devices (e.g., transcatheter mitral valve therapies).
$230.52B
$132.57
-1.21%
SYK Stryker Corporation 70%
Prosthetics & Implants - implants and prosthetic components across orthopedics and related areas.
$139.34B
$364.60
-1.54%
MDT Medtronic plc 80%
Prosthetics & Implants encompasses spine implants and other MDT implant technologies within the AiBLE spine ecosystem.
$122.30B
$95.45
-1.27%
EW Edwards Lifesciences Corporation 75%
Heart valve implants (prosthetic valves and related implants) fit under Prosthetics & Implants as a major product category.
$43.37B
$73.94
-1.58%
ZBH Zimmer Biomet Holdings, Inc. 90%
Oxford Partial Cementless Knee and Persona IQ smart knee implants fall under prosthetic implants.
$19.84B
$99.20
-1.08%
SNNUF Smith & Nephew plc 85%
Implantable prosthetics and implants portfolio (hip/knee), aligned with prosthetics & implants category.
$15.42B
$17.71
HSIC Henry Schein, Inc. 90%
Includes prosthetics and implants (e.g., dental implants) as part of specialty products.
$7.69B
$63.17
-2.35%
GMED Globus Medical, Inc. 92%
Prosthetics & Implants across musculoskeletal segments (spinal spacers, knee implants, etc.).
$7.66B
$56.57
-5.32%
MMSI Merit Medical Systems, Inc. 85%
Prosthetics & Implants includes cardiovascular implants and endoprostheses like WRAPSODY and GERD-related devices.
$4.67B
$78.99
-3.99%
NVST Envista Holdings Corp 95%
Nobel Biocare premium implants, Alpha-Bio, and Implant Direct are prosthetics/implants products.
$3.23B
$19.06
-4.94%
OGN Organon & Co. 65%
Nexplanon implant and Jada System are prosthetics/implants and medical devices.
$2.75B
$10.65
+0.80%
XRAY DENTSPLY SIRONA Inc. 85%
Offers dental prosthetics and implants as part of its product lineup.
$2.49B
$12.50
+2.21%
LMAT LeMaitre Vascular, Inc. 85%
Biologic grafts and patches used in vascular surgery are prosthetics & implants.
$1.90B
$86.56
+2.82%
ENOV Enovis Corporation 90%
Produces prosthetic implants and revision components (e.g., cones, stems) as part of reconstructive offerings.
$1.74B
$30.20
-0.85%
AORT Artivion, Inc. 85%
Implantable prosthetic devices (valves and arch repair systems) are a core product category.
$1.72B
$40.20
-1.18%
UFPT UFP Technologies, Inc. 65%
The company’s work with orthopedic implants as an application area supports a prosthetics & implants related product category.
$1.50B
$195.22
+0.25%
CNMD CONMED Corporation 80%
BioBrace qualifies as a prosthetic/implant used in soft tissue repair procedures.
$1.32B
$42.68
-6.42%
ESTA Establishment Labs Holdings Inc. 92%
Motiva Implants are prosthetic breast implants manufactured and sold by ESTA for aesthetics and reconstruction.
$1.22B
$41.43
-2.03%
IART Integra LifeSciences Holdings Corporation 85%
PriMatrix, SurgiMend, and DuraSorb are implantable tissue repair products and implants.
$1.04B
$13.34
-5.86%
AXGN AxoGen, Inc. 90%
Implantable nerve repair solutions (Avance Nerve Graft and Axoguard) fall under prosthetics/implants.
$728.25M
$15.99
-2.26%
SIBN SI-BONE, Inc. 70%
Prosthetic implants and osteoskeletal devices align with SI-BONE's implant-based solutions for orthopedic/spine procedures.
$629.84M
$14.78
-5.80%
OFIX Orthofix Medical Inc. 75%
Limb reconstruction implants and prosthetic-related devices (e.g., TrueLok Elevate system).
$556.37M
$14.20
+1.50%
ZIMV ZimVie Inc. 95%
Directly manufactures dental implants and related prosthetic dental implant devices (premium implant platforms).
$527.72M
$18.91
+0.08%
ORGO Organogenesis Holdings Inc. 60%
Dermal substitutes and tissue-implant-like products function as tissue substitutes/implants in wound care, aligning with prosthetics & implants.
$502.34M
$3.96
-2.46%
KIDS OrthoPediatrics Corp. 84%
Prosthetics & Implants category covers pediatric orthopedic implants and related devices used in surgeries.
$452.78M
$17.93
-1.94%
TMCI Treace Medical Concepts, Inc. 85%
Implant components used in Lapiplasty and other 3D correction procedures.
$418.95M
$6.66
-0.15%
DDD 3D Systems Corporation 75%
Prosthetics & Implants: patient-specific, 3D-printed implants (e.g., PEEK implants) enabled by AM.
$394.23M
$2.89
-9.69%
SMTI Sanara MedTech Inc. 75%
OsStic bone void filler and related implant technologies fit Prosthetics & Implants.
$277.21M
$31.09
-0.32%
HUMA Humacyte, Inc. 92%
Symvess is an implantable vascular conduit (prosthetic/implantable device) derived from bioengineered tissue, directly aligning with Prosthetics & Implants.
$241.99M
$1.56
-4.29%
AVR Anteris Technologies Global Corp. 75%
The DurAVR system is an implantable prosthetic device for the cardiovascular system.
$166.25M
$4.61
-6.11%
ANIK Anika Therapeutics, Inc. 80%
Integrity Implant System and Hyalofast are implantable prosthetics/regenerative implants.
$131.49M
$9.12
-1.51%
XTNT Xtant Medical Holdings, Inc. 80%
XTNT offers orthopedic/regenerative implants and prosthetics as core offerings.
$99.70M
$0.72
-3.30%
VANI Vivani Medical, Inc. 92%
NanoPortal implants are prosthetic/implant devices designed to deliver drugs over an extended period.
$81.16M
$1.37
-2.14%
TELA TELA Bio, Inc. 92%
TELA produces OviTex Reinforced Tissue Matrix implants (OviTex PRS, OviTex IHR) for soft tissue reconstruction, a clear fit for the Prosthetics & Implants category.
$59.33M
$1.49
-0.67%
NMTC NeuroOne Medical Technologies Corporation 75%
Implantable brain and spinal cord stimulation components align with prosthetics & implants.
$47.33M
$0.95
-7.77%
ELUT Elutia Inc. 78%
SimpliDerm and related biomatrix-based implant/reconstructive products align with prosthetics & implants, a core category for devices that interact with or replace body tissues.
$36.18M
$0.89
+1.02%
MYO Myomo, Inc. 92%
Myomo's core product is the MyoPro myoelectric orthotic device, a prosthetics/implant category enabling upper-limb movement.
$33.50M
$0.91
-12.50%
CLGN CollPlant Biotechnologies Ltd. 65%
Prosthetics & Implants: regenerative breast implant and rhCollagen-based implants.
$25.20M
$2.20
-6.38%
COCH Envoy Medical, Inc. 92%
Envoy Medical's Acclaim Cochlear Implant and Esteem FI-AMEI are implanted prosthetic devices designed to treat hearing loss.
$18.87M
$0.89
-8.29%
NVNO enVVeno Medical Corporation 90%
The VenoValve and enVVe are prosthetic tissue-based implant devices, fitting the 'Prosthetics & Implants' category.
$13.01M
$0.74
-14.74%
SINT Sintx Technologies, Inc. 80%
Potential prosthetic implants (spinal, dental) align with Prosthetics & Implants given the implant-focused product roadmap.
$10.31M
$4.11
+7.31%
LYRA Lyra Therapeutics, Inc. 90%
LYR-210 is an implantable prosthetic/implant delivering localized corticosteroid therapy, categorizing under Prosthetics & Implants.
$10.17M
$7.67
-1.67%
EKSO Ekso Bionics Holdings, Inc. 70%
Exoskeletons function as external mobility prosthetics, fitting Prosthetics & Implants.
$9.56M
$4.94
-8.86%
LFWD Lifeward Ltd. 92%
ReWalk exoskeletons and related wearable mobility devices are prosthetics/implant-type products directly manufactured and sold by Lifeward.
$8.79M
$0.80
-5.39%
TNON Tenon Medical, Inc. 78%
Company sells prosthetic implants (Catamaran, SiVantage/SIMPL, Symmetry Plus) used in sacroiliac and spinal fusion surgeries.
$8.65M
$1.14
-4.20%
TTNP Titan Pharmaceuticals, Inc. 65%
Titan historically produced Probuphine, a subdermal implant (drug-delivery implant), which aligns with the Prosthetics & Implants category.
$4.21M
$4.61
-3.76%

Loading industry metrics...

Loading comparison data...

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks